# Severe Malaria Infection Concurrent With Autoimmune Hemolytic Anemia and Acute Cytomegalovirus Infection: A Case Report

**Authors:** Shuaib Alsibai, Mohamad K Mohamad, Yousef S Alabrach, Ahmed Osman

PMC · DOI: 10.7759/cureus.81597 · Cureus · 2025-04-02

## TL;DR

A 33-year-old woman had severe malaria, autoimmune anemia, and a CMV infection at the same time, showing the need for combined treatment and monitoring for lupus.

## Contribution

Reports a rare case of concurrent malaria, AIHA, and acute CMV infection, highlighting treatment and monitoring strategies.

## Key findings

- The patient improved with antimalarial and prednisolone therapy.
- High ANA titers and low complements suggested an underlying autoimmune disorder like SLE.
- The case highlights the importance of combined antimalarial and immunosuppressive treatment.

## Abstract

Malaria infection causes lysis of infected red blood cells (RBCs), leading to anemia. Autoimmune hemolytic anemia (AIHA), on the other hand, is caused by antibody-mediated destruction of RBCs, and it is associated with other autoimmune disorders like systemic lupus erythematosus (SLE). Thereby, we report a rare case of concurrent malaria infection with AIHA and acute cytomegalovirus (CMV) infection. A 33-year-old female presented with fever for seven days. She came back from Ethiopia 40 days ago. She was found to have severe anemia, and further workup revealed high levels of immunoglobulin G (IgG) antibodies against RBC. She rapidly improved with antimalarial and prednisolone therapy. She was also found to have immunoglobulin M (IgM) against CMV, indicating acute infection, but she didn't have specific manifestations related to CMV and therefore was not treated. During outpatient follow-up, she was found to have high antinuclear antibody (ANA) titers as well as low complements, indicating the possibility of an underlying autoimmune disorder. This case underscores the need for concurrent antimalarial and immunosuppressive therapy in co-occurring autoimmune hemolytic anemia (AIHA)/malaria, with close monitoring for SLE progression given high ANA titers.

## Linked entities

- **Diseases:** malaria (MONDO:0005136), autoimmune hemolytic anemia (MONDO:0020108), systemic lupus erythematosus (MONDO:0007915), cytomegalovirus infection (MONDO:0005132)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** infection (MESH:D007239), autoimmune disorder (MESH:D001327), fever (MESH:D005334), Cytomegalovirus Infection (MESH:D003586), AIHA (MESH:D000744), Malaria Infection (MESH:D008288), SLE (MESH:D008180), anemia (MESH:D000740)
- **Chemicals:** prednisolone (MESH:D011239)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12048128/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12048128/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12048128/full.md

---
Source: https://tomesphere.com/paper/PMC12048128